BlackRock, Inc. 13D and 13G filings for Bristol-Myers Squibb Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Bristol-Myers Squibb Company BMY |
BlackRock Inc. BLK |
143,574,230 7.100% |
-24,523,997 (-14.59%) |
Filing |
| 2024-01-25 4:59 pm Sale |
2023-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BlackRock Inc. BLK |
168,098,227 8.300% |
-4,622,150 (-2.68%) |
Filing |
| 2023-02-07 2:10 pm Purchase |
2022-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BlackRock Inc. BLK |
172,720,377 8.100% |
3,493,671 (+2.06%) |
Filing |
| 2022-01-31 5:59 pm Sale |
2021-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BlackRock Inc. BLK |
169,226,706 7.600% |
-3,238,098 (-1.88%) |
Filing |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BlackRock Inc. BLK |
172,464,804 7.600% |
1,121,358 (+0.65%) |
Filing |